A Study to Learn About a COVID-19 Vaccine in Healthy Adults 50 Through 64 Years of Age

Running, not enrolling · Phase 3 · Has a placebo group

Conditions studied: COVID-19, SARS-COV-2 Infection

In brief

This study is designed to find out how well the COVID-19 vaccine protects people 50 to 64, who don't have any serious health problems, compared to a group that receives a vaccine that doesn't contain an ingredient to protect against COVID-19 (placebo).

Key facts

Study ID
NCT07300839
Run by
BioNTech SE
People needed
5240
Starts
2025-12-10
Expected to finish
2026-07-31
Last updated by the study team
2026-04-13

Who can join

Age: 50 and older, up to 64. Sex: any. Healthy volunteers: accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.